Journal of Data Mining in Genomics & Proteomics

Impacts and Challenges of Next-Generation Sequencing in Genomics

Patrick S Myers^* Department of Biochemistry and Molecular Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California, United States of America
^*Correspondence: Patrick S Myers, Department of Biochemistry and Molecular Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California, United States of America, Email:

Received: 20-Nov-2024, Manuscript No. JDMGP-24-27975; Editor assigned: 22-Nov-2024, Pre QC No. JDMGP-24-27975 (PQ); Reviewed: 06-Dec-2024, QC No. JDMGP-24-27975; Revised: 13-Dec-2024, Manuscript No. JDMGP-24-27975 (R); Published: 20-Dec-2024, DOI: 10.4172/2153-0602.24.15.363

Description

Next-Generation Sequencing (NGS) has revolutionized the field of genomics by enabling rapid, high-throughput analysis of DNA and RNA. This transformative technology has deeply impacted research, diagnostics and personalized medicine by providing unprecedented insights into the genetic basis of diseases and biological processes. However, alongside its remarkable contributions, NGS poses several challenges that need to be addressed to fully realize its potential. This article describes the impacts of NGS on genomics and search into the associated challenges that continue to shape its application.

The impacts of NGS on genomics

NGS has fundamentally changed the way genetic information is studied and applied. Its ability to sequence millions of DNA fragments simultaneously has allowed researchers to move beyond traditional sequencing methods, such as Sanger sequencing, to tackle complex questions in genomics with greater speed and accuracy [1-3].

Accelerating genomic research: One of the most significant impacts of NGS is the acceleration of genomic research. By enabling large-scale sequencing, NGS has facilitated the assembly and annotation of whole genomes, including those of humans, animals, plants and microorganisms. For example, the sequencing of the human genome, which took over a decade with earlier methods, can now be accomplished in just a few days using NGS. This rapid sequencing capability has driven advancements in evolutionary biology, comparative genomics and biodiversity studies [4].

Advancing personalized medicine: In the region of healthcare, NGS has become a fundamental of personalized medicine. The technology enables comprehensive genomic profiling of patients, leading to precise diagnosis and targeted therapies. For instance, NGS is extensively used in oncology to identify genetic mutations associated with cancer and to guide treatment decisions. Similarly, in rare disease diagnosis, NGS has helped uncover previously unidentified genetic mutations, providing answers to patients and families who had long sought explanations for their conditions [5].

Enabling transcriptomics and epigenomics: NGS is not limited to DNA sequencing; it has also transformed transcriptomics and epigenomics. RNA sequencing (RNA-seq) has become a standard tool for studying gene expression and uncovering regulatory mechanisms. Meanwhile, epigenomic studies leveraging NGS have explain the DNA modifications and chromatin dynamics, suggesting insights into how gene activity is regulated and how these processes are altered in diseases such as cancer and neurological disorders [6,7].

Supporting microbial and environmental genomics: NGS has also made significant contributions to microbial and environmental genomics. Metagenomic sequencing, for instance, allows researchers to study the genetic diversity of microbial communities in various environments without the need for culturing individual organisms. This has advanced our understanding of the microbiome's role in health, disease and ecosystems [8].

Challenges of NGS in genomics

Despite its transformative impacts, NGS is not without challenges. These challenges span technical, analytical and ethical domains, limiting the broader application of the technology in research and clinical settings.

Data management and analysis: One of the primary challenges of NGS is the sheer volume of data it generates. A single sequencing run can produce terabytes of raw data, requiring strong computational infrastructure and bioinformatics expertise for storage, processing and analysis. Interpreting the data is another hurdle, as it involves distinguishing meaningful biological signals from noise, annotating variants and integrating multi-omics datasets. The lack of standardized pipelines and tools for data analysis further complicates these tasks, particularly for small research teams or institutions with limited resources [9].

Cost and accessibility: Although the cost of sequencing has decreased dramatically since the advent of NGS, it remains a barrier for many researchers and healthcare systems, particularly in low- and middle-income countries. Beyond sequencing costs, the expenses associated with data storage, analysis and interpretation add to the financial burden. These factors limit the global accessibility of NGS and hinder its equitable implementation in clinical and research settings.

Accuracy and technical limitations: While NGS suggest high- throughput sequencing, it is not immune to technical limitations. Errors in base calling, especially in regions with repetitive sequences or high GC content, can lead to inaccuracies. Additionally, short-read sequencing platforms, which are widely used, struggle to resolve structural variants and long genomic repeats. Long-read sequencing technologies, such as those suggested by PacBio and Oxford Nanopore, aim to address these limitations but are currently less widely adopted due to higher costs and lower throughput compared to short- read platforms.

Ethical and privacy concerns: The ethical implications of NGS are a growing concern, particularly regarding the handling of genetic data. The potential for misuse of genomic information raises questions about privacy, consent and data security. For example, whole-genome sequencing may reveal incidental findings, such as predispositions to untreatable diseases, posing ethical dilemmas for researchers and clinicians. Additionally, ensuring that data sharing complies with regulations while respecting individuals' rights remains a significant challenge.

Integration into clinical practice: Translating NGS findings into clinical practice presents logistical and regulatory challenges. Validating and standardizing NGS assays for clinical use requires rigorous quality control and compliance with regulatory standards. Furthermore, integrating NGS into routine healthcare systems demands training for healthcare providers, as well as the development of guidelines for interpreting and acting upon genomic data [10].

Future directions

Addressing the challenges of NGS requires collaborative efforts across disciplines. Investments in bioinformatics infrastructure, cloud computing and machine learning can enhance data management and analysis. Initiatives to develop cost-effective sequencing technologies and provide financial support to resource-limited settings are essential for improving accessibility.

Long-read sequencing technologies are expected to complement short-read platforms, suggesting more accurate resolution of complex genomic regions. Additionally, multi-omics approaches that combine genomics, transcriptomics, proteomics and metabolomics will provide a more holistic understanding of biological systems, driving further advancements in personalized medicine and disease research.

Conclusion

Next-generation sequencing has transformed genomics by enabling high-throughput, precise and comprehensive analyses of genetic information. Its impacts on research, medicine and environmental studies are extreme, preparing for innovative discoveries. However, challenges related to data analysis, cost, technical limitations and ethics must be addressed to fully control its potential. By overcoming these obstacles, NGS can continue to drive progress in genomics and contribute to a deeper understanding of life and its complexities.

References

1. Behjati S, Tarpey PS. What is next generation sequencing?. Arch Dis Child Educ Pract Ed. 2013;98(6):236-238.

   [Crossref] [Google Scholar] [PubMed]

2. Zhang J, Chiodini R, Badr A, Zhang G. The impact of next-generation sequencing on genomics. J Genet Genomic. 2011;38(3):95-109.

   [Crossref] [Google Scholar] [PubMed]

3. Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet. 2008;24(3):133-1341.

   [Crossref] [Google Scholar] [PubMed]

4. Bleidorn C. Third generation sequencing: technology and its potential impact on evolutionary biodiversity research. Syst biodivers. 2016;14(1):1-8.

   [Crossref] [Google Scholar]

5. Frese KS, Katus HA, Meder B. Next-generation sequencing: From understanding biology to personalized medicine. Biology. 2013;2(1):378-398.

   [Crossref] [Google Scholar] [PubMed]

6. Wu PY, Chandramohan R, Phan JH, Mahle WT, Gaynor JW, Maher KO, et al. Cardiovascular transcriptomics and epigenomics using next-generation sequencing: Challenges, progress and opportunities. Circ Cardiovasc Genet. 2014;7(5):701-710.

   [Crossref] [Google Scholar] [PubMed]

7. Mensaert K, Denil S, Trooskens G, Van Criekinge W, Thas O, De Meyer T. Next‐generation technologies and data analytical approaches for epigenomics. Environ Mol Mutagen. 2014;55(3):155-170.

   [Crossref] [Google Scholar] [PubMed]

8. Neelapu NR, Surekha C. Next-generation sequencing and metagenomics. In Computational biology and bioinformatics: gene regulation. CRC Press, Boca Raton. 2016:331-351.

   [Google Scholar]

9. Veltman JA, Cuppen E, Vrijenhoek T. Challenges for implementing next-generation sequencing-based genome diagnostics: It‘s also the people, not just the machines. Per Med. 2013;10(5):473-484.

   [Crossref] [Google Scholar] [PubMed]

10. Bowdin S, Gilbert A, Bedoukian E, Carew C, Adam MP, Belmont J, et al. Recommendations for the integration of genomics into clinical practice. Genet Med. 2016;18(11):1075-1084.

    [Crossref] [Google Scholar] [PubMed]